Published in Oral Oncol on April 09, 2009
The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer. Cell Cycle (2012) 1.56
The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas. Br J Cancer (2012) 1.07
Ubiquitin-specific cysteine protease 2a (USP2a) regulates the stability of Aurora-A. J Biol Chem (2011) 0.97
Fatty acid synthase overexpression in adult testicular germ cell tumors: potential role in the progression of non-seminomatous germ cell tumors. Virchows Arch (2013) 0.81
Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration. PLoS One (2014) 0.81
The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis. Oncotarget (2013) 0.80
USP35 activated by miR let-7a inhibits cell proliferation and NF-κB activation through stabilization of ABIN-2. Oncotarget (2015) 0.78
FASN expression, angiogenesis and lymphangiogenesis in central and peripheral giant cell lesions. J Appl Oral Sci (2014) 0.78
Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread. Clin Exp Metastasis (2013) 0.77
p53 signaling is involved in leptin-induced growth of hepatic and breast cancer cells. Korean J Physiol Pharmacol (2016) 0.75
Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis. BMC Urol (2015) 0.75
Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model. Lab Invest (2016) 0.75
Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review. Curr Genomics (2017) 0.75
DUBbing Cancer: Deubiquitylating Enzymes Involved in Epigenetics, DNA Damage and the Cell Cycle As Therapeutic Targets. Front Genet (2016) 0.75
Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer (2005) 3.27
Hereditary gingival fibromatosis: a systematic review. J Periodontol (2006) 2.24
Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res (2003) 1.83
The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci U S A (2003) 1.79
Cytokeratin expression in central mucoepidermoid carcinoma and glandular odontogenic cyst. Oral Oncol (2004) 1.69
Pectoralis major and other myofascial/myocutaneous flaps in head and neck cancer reconstruction: experience with 437 cases at a single institution. Head Neck (2004) 1.66
Comparison of two prognostic scores for patients with parotid carcinoma. Head Neck (2009) 1.55
Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancer. Cancer Res (2005) 1.47
Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res (2005) 1.46
Detection of micrometastases in pN0 non-small cell lung cancer: an alternative method combining tissue microarray and immunohistochemistry. J Bras Pneumol (2008) 1.41
Oral myofibromas: report of two cases and review of clinical and histopathologic differential diagnosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 1.30
Cutaneous angiosarcoma of the head and neck: report of 23 cases from a single institution. Otolaryngol Head Neck Surg (2008) 1.28
GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma. Molecules (2010) 1.27
Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int J Cancer (2008) 1.25
Computed tomography guided needle biopsy: experience from 1,300 procedures. Sao Paulo Med J (2006) 1.23
Prognostic factors in head and neck mucoepidermoid carcinoma. Arch Otolaryngol Head Neck Surg (2004) 1.23
Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol (2007) 1.23
Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head Neck (2010) 1.22
Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol (2005) 1.22
Risk factors for stomach cancer in Brazil (I): a case-control study among non-Japanese Brazilians in São Paulo. Jpn J Clin Oncol (2002) 1.22
Overexpression of HOXB7 homeobox gene in oral cancer induces cellular proliferation and is associated with poor prognosis. Int J Oncol (2010) 1.22
Salivary gland tumors in children and adolescents: a clinicopathologic and immunohistochemical study of fifty-three cases. Int J Pediatr Otorhinolaryngol (2004) 1.21
Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas. Oral Oncol (2003) 1.21
Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation. Cancer Res (2003) 1.20
Surgical complications after thyroid surgery performed in a cancer hospital. Otolaryngol Head Neck Surg (2005) 1.20
Oral verrucous carcinoma: a retrospective study in São Paulo Region, Brazil. Clin Oral Investig (2006) 1.20
Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol (2004) 1.20
Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg (2003) 1.19
Risk factors for stomach cancer in Brazil (II): a case-control study among Japanese Brazilians in São Paulo. Jpn J Clin Oncol (2002) 1.19
Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts. Int J Cancer (2009) 1.19
Families' interactions with physicians in the intensive care unit: the impact on family's satisfaction. J Crit Care (2007) 1.17
Giant pleomorphic adenoma of the parotid gland. Med Oral Patol Oral Cir Bucal (2008) 1.13
Structural features and transcript-editing analysis of sugarcane (Saccharum officinarum L.) chloroplast genome. Curr Genet (2004) 1.13
Penile squamous cell carcinoma clinicopathological features, nodal metastasis and outcome in 333 cases. J Urol (2009) 1.12
Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression. Oncol Rep (2010) 1.11
Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol (2007) 1.11
Histologic subtypes of oral squamous cell carcinoma: prognostic relevance. J Can Dent Assoc (2007) 1.11
Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis. Lab Invest (2010) 1.10
Predictive factors and distribution of lymph node metastasis in lip cancer patients and their implications on the treatment of the neck. Oral Oncol (2004) 1.09
Prognoses of oral basaloid squamous cell carcinoma and squamous cell carcinoma: a comparison. Arch Otolaryngol Head Neck Surg (2004) 1.09
Adenoid cystic carcinoma and mucoepidermoid carcinoma of the maxillary sinus: report of a 44-year experience of 25 cases from a single institution. J Oral Maxillofac Surg (2006) 1.08
Nonlymphoid mesenchymal tumors of the parotid gland. Oral Oncol (2008) 1.07
Goldenhar syndrome: clinical features with orofacial emphasis. J Appl Oral Sci (2010) 1.04
Clinical predictors of quality of life in patients with initial differentiated thyroid cancers. Arch Otolaryngol Head Neck Surg (2009) 1.04
Multiple granular cell tumors of the tongue and parotid gland. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 1.04
Rhabdomyosarcoma of the head and neck: a clinicopathological and immunohistochemical analysis of 29 cases. Braz Dent J (2010) 1.02
Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis. Virchows Arch (2008) 1.01
Plasmacytoid myoepithelioma of the palate in a child. Int J Paediatr Dent (2007) 1.01
Gene expression arrays in cancer research: methods and applications. Crit Rev Oncol Hematol (2005) 1.01
Down-regulation of the candidate tumor suppressor gene PAR-4 is associated with poor prognosis in breast cancer. Int J Oncol (2010) 1.00
The fatty acid synthase inhibitor orlistat reduces the growth and metastasis of orthotopic tongue oral squamous cell carcinomas. Mol Cancer Ther (2013) 1.00
Tissue eosinophilia and its association with tumoral invasion of oral cancer. Int J Surg Pathol (2009) 1.00
Influence of the interaction between nodal fibroblast and breast cancer cells on gene expression. Tumour Biol (2010) 0.99
Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil. PLoS One (2013) 0.99
HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis. BMC Cancer (2012) 0.99
Intraneural perineurioma of the tongue: a case report. J Oral Maxillofac Surg (2006) 0.98
Papillary squamous cell carcinoma of the tongue. Otolaryngol Head Neck Surg (2009) 0.98
Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas. Clinics (Sao Paulo) (2012) 0.98
Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck (2006) 0.97
Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer. Arch Otolaryngol Head Neck Surg (2003) 0.97
Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors. Transl Oncol (2010) 0.97
Primary oral mucosal melanoma: a series of 35 new cases from South America. Am J Dermatopathol (2009) 0.97
High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Cancer Res (2010) 0.97
Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer. J Clin Endocrinol Metab (2010) 0.97
Quality of life related to swallowing after tongue cancer treatment. Dysphagia (2007) 0.97
Myofibroblasts in the stroma of oral cancer promote tumorigenesis via secretion of activin A. Oral Oncol (2011) 0.97
Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation. Endocr Relat Cancer (2013) 0.96
The role of eosinophils and eosinophil cationic protein in oral cancer: a review. Arch Oral Biol (2010) 0.96
Voice and vocal self-assessment after thyroidectomy. Head Neck (2006) 0.96
CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients. Oral Oncol (2009) 0.95
Postoperative complications of thyroidectomy for differentiated thyroid carcinoma. Am J Otolaryngol (2004) 0.94
Tyrosine kinase receptor expression in chordomas: phosphorylated AKT correlates inversely with outcome. Hum Pathol (2013) 0.94
Expression of cancer/testis antigens is correlated with improved survival in glioblastoma. Oncotarget (2013) 0.94
Immunohistochemical expression of p63 in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands. Oral Oncol (2005) 0.93
Distribution of metastatic lymph nodes in oropharyngeal carcinoma and its implications for the elective treatment of the neck. Arch Otolaryngol Head Neck Surg (2003) 0.93
Recurrent oral cancer: current and emerging therapeutic approaches. Front Pharmacol (2012) 0.93
Sex with animals (SWA): behavioral characteristics and possible association with penile cancer. A multicenter study. J Sex Med (2011) 0.93
Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients. Oral Oncol (2011) 0.93
Clinicopathological and immunohistochemical evaluation of oral squamous cell carcinoma in patients with early local recurrence. Oral Oncol (2006) 0.93
Management of extensive osteoradionecrosis of the mandible with radical resection and immediate microvascular reconstruction. J Oral Maxillofac Surg (2007) 0.92
Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas. Med Sci Monit (2002) 0.92
CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients. Head Neck (2011) 0.92
Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg (2008) 0.92
TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors. J Transl Med (2013) 0.92
High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer (2011) 0.92